Cargando…
Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
Dendritic cell (DC) based cancer vaccines represent a promising immunotherapeutic strategy against cancer. To enhance the modest immunogenicity of DC vaccines, various adjuvants are often incorporated. Particularly, most of the common adjuvants are derived from bacteria. In the current study, we eva...
Autores principales: | Kang, Tae Heung, Kim, Young Seob, Kim, Seokho, Yang, Benjamin, Lee, Je-Jung, Lee, Hyun-Ju, Lee, Jaemin, Jung, In Duk, Han, Hee Dong, Lee, Seung-Hyun, Koh, Sang Seok, Wu, T.-C., Park, Yeong-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695023/ https://www.ncbi.nlm.nih.gov/pubmed/26336989 |
Ejemplares similares
-
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
por: Park, Hyun Jin, et al.
Publicado: (2019) -
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor
por: Yoo, Wonbeak, et al.
Publicado: (2021) -
Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2018) -
A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014) -
Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
por: Jeong, Hyein, et al.
Publicado: (2022)